SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Skye Bioscience, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.53−0.02 (-1.29%)
Close on Oct 19, 2026
- Market cap
- $60.73M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 24, 2026 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Sep 8, 2023 | 1-for-250 reverse | Earlier per-share figures multiplied by 250 |
| Sep 6, 2023 | 1-for-250 reverse | Earlier per-share figures multiplied by 250 |